18 Tool Calls, Two and a Half Minutes: How Senti Tackled a Complex Healthcare Data Question

Imagine a healthcare data warehouse with 3 million rows across 11 tables. Encounters, conditions, patients, payers, and medications. All loosely connected.

You ask a simple question: "Which chronic conditions have the highest 30-day hospital readmission rates?"

Sounds simple enough. But there's no "readmission" column in the data. To answer it, a data engineer would need to join encounters to conditions, define time windows, filter by encounter type, handle edge cases, and understand the schema well enough to know where to start. That could take hours of work.

We pointed Senti at the same warehouse and asked the same question. It explored the schema, identified that a strict inpatient-only approach was too narrow, broadened its strategy to include emergency visits, adjusted thresholds, and delivered clinically meaningful readmission rates — broken down by condition, with cost analysis included.

18 tool calls. Two and a half minutes. Zero human intervention.

Ask questions in plain English, get validated SQL and instant visualizations.

• Fast for quick lookups
• Balanced for everyday analysis
• Validated for mission-critical queries with full self-correction

Every answer shows the AI's reasoning steps, the SQL it wrote, and the schema it used. No black box.

Same question, same answer — every time. That's a big deal for enterprise AI adoption.

Connects to 11+ data sources: Snowflake, BigQuery, Redshift, Databricks, Azure Synapse, PostgreSQL, and more. Export to Power BI, Tableau, or QuickSight.

Consistency and transparency should be the norm, not the exception.

Senti launches in May 2026. Early access pricing is available now. If your data has answers your team hasn't had time to find yet, let's talk.

Rayson Technologies is building Senti to transform how organizations interact with their data. Natural language queries, validated SQL, and instant insights across your entire data ecosystem. Contact us to learn more about early access.